Food ingredients group Danisco lifted its full-year profit target today (16 December) after booking a jump in second-quarter earnings.

The Denmark-based group expects net profit for the 12 months to the end of April to reach DKK1.3bn (US$230.2m), up from its previous forecast of DKK1.2bn.

Danisco also outlined an improved target for EBIT before its Bio Chemicals Projects (BCP) of DKK2.2-2.3bn. The company had forecast DKK2.1-2.2bn.

During the second quarter of Danisco’s financial year, its net profit grew 59% to DKK371m. EBIT before BCP stood at DKK623m, up from DKK407m. Including BCP, EBIT grew from DKK394m to DKK607 in the current fiscal year.

Danisco said the rise in EBIT reflected a “stronger performance in all key business areas driven by factors such as a broad-based, improved product offering and production efficiencies”.

The company booked an 18% increase in revenue to DKK3.8bn and it upped its revenue target for the full year from DKK15bn to DKK15.3bn.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

CEO Tom Knutzen said: “Q2 was another strong quarter for Danisco. We can now confidently say that our sweeteners division is on track to recover profitability. It is also evident that we have established a new earnings level for [enzymes division] Genencor and cultures. And earnings will remain strong for Enablers, even if we are now entering a different phase of the business cycle due to substantial raw material price hikes. Thus we are ready for a new chapter of investing into our future growth platform while maintaining earnings progression.”

Shares in Danisco were up 4.6% at DKK502 at 16:08 CET.

Click here for the full statement from Danisco.